Roche announced that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox. Mpox, a viral disease that can spread easily between people and from infected animals, was declared a Public Health Emergency of International Concern by the World Health Organization, WHO. Globally, Roche is partnering with governments, healthcare providers and organisations dedicated to combating the mpox outbreak. More specifically, Roche is actively working with its partners to enhance mpox laboratory capacity worldwide. In addition, Roche provides training for laboratories across the African continent at the Roche Scientific Campus in South Africa, as well as locally.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
- Lixte Biotechnology provides update on recent activities, developments
- Cisco, Walmart report quarterly earnings beats: Morning Buzz
- Biden administration announces lower prices for 10 Medicare drugs in 2026
- Roche passed on weight-loss pilll now being developed by Eli Lilly, FT says